Scott Okuno, M.D.

Mayo Clinic
Rochester, Minnesota, United States

Disclosure information not submitted.

Presentation(s):

• Paper 22 - A PHASE II STUDY OF CABOZANTINIB AND TEMOZOLOMIDE IN PATIENTS WITH UNRESECTABLE OR METASTATIC LEIOMYOSARCOMA AND OTHER SOFT TISSUE SARCOMAS

  Thursday, November 2, 2023
  4:00 PM – 5:30 PM